GLP-1s Are About More Than Weight Loss – The Expanding Science Behind Inflammation, Longevity, and Chronic Disease with Dr. Aaron Hartman | GLP-1 | E148

🔥 Curious why GLP-1 medications are making headlines far beyond weight loss? Read UnCurable to explore a deeper perspective on inflammation, chronic illness, and the future of personalized medicine.What if GLP-1 medications are doing far more than helping people lose weight?In this solo episode of Made for Health, Dr. Aaron Hartman takes a deep dive into the science, history, and evolving role of GLP-1 medications, one of the most widely discussed classes of therapies in modern medicine.Drawing from nearly two decades of clinical experience, he explains how GLP-1 medications have progressed from diabetes treatments to therapies being explored for obesity, cardiovascular disease, kidney health, sleep apnea, inflammation, and neurological conditions. He also addresses common misconceptions about safety, side effects, and why proper dosing plays a critical role in treatment success.The conversation highlights emerging applications of GLP-1 therapies within functional medicine, including their potential impact on chronic inflammation, mast cell activation, POTS, dysautonomia, and other complex chronic health conditions. Dr. Hartman also emphasizes that no medication replaces the importance of foundational lifestyle habits such as nutrition, sleep, exercise, and environmental health.Key Topics CoveredThe history and evolution of GLP-1 medications from diabetes treatment to modern therapeuticsWhy GLP-1 therapies are not as new as many people believeThe differences between semaglutide, tirzepatide, and emerging therapies like retatrutideHow GLP-1 medications support blood sugar regulation and weight managementThe cardiovascular and kidney-protective benefits of GLP-1 therapiesWhy proper dosing is critical for minimizing side effects and improving outcomesCommon misconceptions about GLP-1 safety and long-term useThe emerging role of GLP-1s in sleep apnea treatmentHow GLP-1 medications may influence inflammation and immune regulationThe connection between GLP-1s, mast cell activation, POTS, and dysautonomiaPotential applications for neurological and neuroinflammatory conditionsWhy obesity is more complex than calories aloneThe different drivers of obesity, including metabolic, inflammatory, toxic, and trauma-related factorsWhy lifestyle foundations remain essential even when using advanced therapiesFollow Dr. Aaron Hartman and Richmond Integrative & Functional Medicine🌐 Website: https://richmondfunctionalmedicine.com/📺 YouTube: @AaronHartmanMD